Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from GSK

Vir Obliterates Quarterly Sales Expectations As Covid Drug Delivers Triple-Digit Growth

Vir Biotechnology obliterated expectations for its Covid drug in the third quarter, and Vir stock leaped above its 200-day line.

Investors Business Daily

Mark Zuckerberg’s metaverse is a joke not shared by investors

Meta’s share price is down 73% in 2022 but Facebook investors can’t force the boss to change course

The Guardian - UK

GSK Slips As Shingles Vaccine Drives Commanding Third-Quarter Beat

GSK stock jumped Wednesday after the company beat third-quarter forecasts due to strength from specialty medicines and Shingrix.

Investors Business Daily

From analysis to the latest developments in health,
read the most diverse news in one place.

Downsizing At Twitter After Musk Takeover, Big Pharma Chains To Pay $14B In Opioid Claims, Tesla Shutters 1st Showroom In China: Top Stories Wednesday, Nov. 02

Reuters

Benzinga

Strong RSV vaccine data lifts hopes after years of futility

A new study suggests vaccinating pregnant women protects their newborns from the common but scary respiratory virus called RSV

The Independent UK

Gareth Thomas thanks ViiV for support in fight against HIV stigma

Gareth Thomas visited GSK House in his latest stop on the Myth Bus Tour.

Wales Online

‘A better partner’: Labour woos big business in bid to oust Rishi Sunak

Wes Streeting and Jonathan Reynolds test water with pharma firm GSK as party prepares for election

The Guardian - UK

Read news from The Economist, FT, and more,
with one subscription

3 Upgraded Stocks to Consider Buying This Week

The red-hot inflation is increasing the odds of continued rate hikes by the Fed. Since the market is expected to remain under pressure on recession fears, it could be wise to invest in fundamentally sound stocks Comcast Corporation (CMCSA), GSK (GSK), and Masonite International (DOOR), which have been recently upgraded…

StockNews.com

GSK vaccine shows ‘exceptional’ efficacy against common lung infection RSV

The pharmaceutical giant’s vaccine was found to be 82.6 per cent effective in Phase III clinical trials

Evening Standard

Oil Output Cut May Tip Global Economy Into Recession, Elon Musk's Starship's First Space Tourist, Alphabet Approves Distribution Of Trump's Truth Social App: Top Stories Thursday, Oct. 13

Reuters

Benzinga

Pollen does more than make you sneeze. It can cause thunderstorm asthma, even if you're not asthmatic

Climate change has caused melting icebergs, flooding, and landslides. It can also bring about an increase in pollen levels, prolong the duration of pollen season, and cause more pollen-related health problems.

The Conversation

Eamonn Holmes shares details of 'ghastly' health scare

Television presenter calls for more awareness and understanding to fight the illness

Wales Online

Questions you should ask your GP if you're concerned about your periods and gynae problems

Research shows one in four people have felt not listened to in a gynae health appointment - checklist shows how you can prepare for GP appointments so it feels less daunting

Daily Mirror

iPhone 14 Popular In China?, Netflix May Lose Comics, Elon Musk's Starlink Slows, Byron Allen Faces $10B Lawsuit And More Top Financial Media Stories Monday, Sept. 26

Bloomberg

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Why Spero Therapeutics Is Trading Higher By Over 105%; Here Are 21 Stocks Moving Premarket

Gainers Spero Therapeutics, Inc. (NASDAQ: SPRO) rose 105.6% to $1.69 in pre-market trading. GSK and Spero Therapeutics announced exclusive license agreement for late-stage antibiotic asset, Tebipenem HBr.

The Guardian - UK

The only party not getting heartburn over GSK demerger is the lawyers

The depressing outcome of the split is a legal challenge in the US over Zantac that will run on for years

Evening Standard

Sensodyne maker Haleon sees 22% profit rise in first results since GSK demerger

Haleon demerged from its parent company in July

StockNews.com

5 “Strong Buy” Health Care Stocks to Buy This Week

Rising prevalence of chronic diseases and the increasing aging population are significant growth drivers of the healthcare industry. Moreover, growing investments in technological advancements should bode well for the industry. Thus, we think investing in quality healthcare stocks Johnson & Johnson (JNJ), Pfizer (PFE), Novo Nordisk (NVO), Bristol-Myers Squibb (BMY),…

Get all your
news in one place.

100’s of premium titles.
One news app.

StockNews.com

3 Health Care Stock Under $50 You Can Buy Today

The healthcare industry is anticipated to grow significantly in the coming years, thanks to strong demand amid rising chronic diseases, technological advancements, and rising healthcare spending. Therefore, we think fundamentally sound healthcare companies Pfizer (PFE), GSK Plc (GSK), and Teva Pharmaceutical (TEVA), which are currently trading under $50, could be…

AFP

New malaria vaccine results raise hopes of mass rollout

Paris (AFP) - A booster dose of a new malaria vaccine maintains a high level of protection against the disease, researchers said Thursday, expressing hopes the cheap jab could be produced on a massive scale in a matter of years.

The Conversation

How should New Zealand manage COVID from now – limit all infections or focus on preventing severe disease?

As the New Zealand government reviews mask mandates and other pandemic measures this week, we argue it’s time to reconsider the overall COVID strategy.

The Independent UK

Chemical engineer fired by pharma giant GlaxoSmithKline after racist, homophobic rant on plane

Man mentioned employer GlaxoSmithKline in rant, calling it ‘one of the best f***ing companies in the world’

Benzinga

Recalled Heartburn Pill Zantac Sets Fire To Glaxo and Sanofi Shares As Billions In Market Value Goes Up In Smoke

Sanofi SA (NASDAQ: SNY), GSK Plc (NYSE: GSK), and Haleon Plc (NYSE: HLN) have lost a combined $40 billion in mar

Investors Business Daily

Pharma Stocks GSK, Sanofi And Haleon Lose Billions As Zantac Trial Looms

Pharmaceutical stocks GSK, Sanofi and Haleon extended deep losses Thursday amid looming litigation around recalled heartburn drug Zantac.

Benzinga

Biotech Daily: Cancer Causing Impurities In Merck's Diabetic Drug, Vir Bio-GSK Shun FDA Submission Plans For COVID-19 Treatment, Aethlon's Monkeypox Trial

Here's a roundup of top developments in the biotech space over the last 24 hours:

1 … 7 8 9 10

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations